Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBushveld Minerals Regulatory News (BMN)

  • This share is currently suspended. It was suspended at a price of 0.306
  • There is currently no data for BMN

Default on Shareholder Loan Repayment by Vanchem

29 Nov 2024 07:00

RNS Number : 1017O
Bushveld Minerals Limited
29 November 2024
 

Market Abuse Regulation (MAR) Disclosure

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement

29 November 2024

Bushveld Minerals Limited

("Bushveld Minerals" "Bushveld" or the "Company")

Default in repayment of shareholder loan amount owing by Vanchem

 

Bushveld Minerals Limited (AIM: BMN), the integrated primary vanadium producer, announces that its group company and former shareholder of Bushveld Vanchem (Pty) Limited ("Vanchem"), Bushveld Vanadium 2 (Pty) Limited ("BV2") has not received an amount of ZAR 14,438,093 (c.US$798,000) less accrued interest, which was due, owing and payable by Vanchem to BV2 by 21 November 2024 (within 14 days of the effective date of Vanchem sale transaction, namely, 7 November 2024), as part-repayment of a shareholder loan balance (plus accrued interest at a rate of 15% per annum and less certain expenses).

The balance of the shareholder loan amount is due in December 2024.

The above payment amount factors in that, on completion of the Vanchem disposal, an amount of ZAR35 million (c.US$1.9 million) was deemed to have already been repaid by Southern Point Resources Fund I S.A. LP ("SPR") owing to kiln repairs that caused the incurrence of unexpected costs associated with the repairs and a period of non-production ("the Estimated Kiln Damages").

The Company disputes the quantum of the ZAR35 million claim, but it has agreed, together with SPR, that an independent expert will be appointed to determine the actual damages. That process has not yet commenced, but once finalised, any difference between the Estimated Kiln Damages and the actual amount will be factored into the deferred consideration still due (i.e., added to the deferred consideration if the actual amount is less than the estimate, or deducted from the deferred consideration if the actual amount is higher than the estimated amount).

Upon receipt, BV2 will utilise the funds as part-payment of an intercompany loan balance owing by BV2 to Bushveld Vametco Alloys (Pty) Limited ("BVA").

Further to the announcement on 19 November 2024, the Company's nominees, Piers Marsden and Jenna Osborne of Matuson & Associates, have now been appointed as the joint business rescue practitioners of BVA, Bushveld Vametco Holdings (Pty) Limited and Bushveld Minerals SA (Pty) Limited ("the Joint BRPs").

Accordingly, the Joint BRPs are currently in discussions with Vanchem and will determine the next steps, including taking legal advice, to recover the amount currently owed by Vanchem to BV2, as outlined above.

Further announcements will be made in due course, as appropriate.

Enquiries :  info@Bushveldminerals.com

Bushveld Minerals Limited

+27 (0) 11 268 6555

Craig Coltman, Chief Executive Officer

SP Angel Corporate Finance LLP

Nominated Adviser & Joint Broker

+44 (0) 20 3470 0470

Richard Morrison / Charlie Bouverat

 

Grant Barker / Abigail Wayne

 

 

Hannam & Partners

Joint Broker

+44 (0) 20 7907 8500

Andrew Chubb / Matt Hasson / Jay Ashfield

 

 

Tavistock

Financial PR

+44 (0) 207 920 3150

Gareth Tredway / Tara Vivian-Neal / James Whitaker

ENDS

 

ABOUT BUSHVELD MINERALS LIMITED

Bushveld Minerals is a primary vanadium producer. It is one of the world's three primary vanadium producers, offering compelling exposure to vanadium through its upstream asset.

Detailed information on the Company and progress to date can be accessed on the website www.bushveldminerals.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDPPGCCGUPCPUR
Date   Source Headline
16th May 20257:00 amRNSCancellation - Bushveld Minerals Limited
15th Apr 20254:28 pmRNSAppointment of Liquidators & Resignation of Nomad
11th Apr 20257:57 amRNSNotice of appointment of liquidators
15th Jan 20256:00 pmRNSBushveld Minerals
16th Dec 20247:15 amRNSBusiness Rescue and Operations Update
4th Dec 20247:00 amRNSResignation of Directors
29th Nov 20247:00 amRNSDefault on Shareholder Loan Repayment by Vanchem
19th Nov 202410:01 amRNSAppointment of Business Rescue Practitioners
18th Nov 20247:30 amRNSSuspension - Bushveld Minerals Limited
18th Nov 20247:00 amRNSTrading Suspension
8th Nov 20249:25 amRNSQ3 and 9M 2024 Operational Update
1st Nov 20243:05 pmRNSVanchem Sale Update
25th Oct 20242:21 pmRNSOperational Update
18th Oct 20249:18 amRNSDisposal of Interests in Lemur Holdings Limited
17th Sep 20247:00 amRNSInterim Results for Six Months ended 30 June 2024
10th Sep 20247:00 amRNSTurnaround Initiatives Underway
2nd Sep 20244:22 pmRNSOrion Matched Funding Received
14th Aug 20246:00 pmRNSSARB Approval for Orion US$10M Matched Funding
12th Aug 20244:13 pmRNSUS$2 million SPR Debt Funding Received
9th Aug 20249:55 amRNSAgreement re Settlement of SPR Subscription Funds
7th Aug 20244:25 pmRNSAnnual General Meeting Results
7th Aug 20247:00 amRNSDirector/PDMR Shareholding
6th Aug 20247:00 amRNSAnnual General Meeting Statement
31st Jul 20247:00 amRNSQ2 and H1 2024 Operational Update
24th Jul 20244:46 pmRNSHolding(s) in Company - Correction
15th Jul 202412:39 pmRNSDirector/PDMR Shareholding
12th Jul 20244:57 pmRNSDirector/PDMR Shareholding
11th Jul 20245:04 pmRNSPosting of Accounts & Notice of General Meeting
28th Jun 20245:30 pmRNSFinal Results for Year Ended 31 December 2023
28th Jun 20243:29 pmRNSFinancing Update: Orion matched funding of US$10m
28th Jun 20241:17 pmRNSHolding(s) in Company
26th Jun 202412:13 pmRNSHolding(s) in Company
24th Jun 20241:50 pmRNSSPR Funding & Orion 2024 Financing Package Update
31st May 20244:07 pmRNSCCSA Approval for sale of 64% interest in Mokopane
31st May 20241:07 pmRNSResult of Meeting
24th May 20245:53 pmRNSShareholder Correspondence and Questions & Answers
13th May 20247:00 amRNSPosting of Circular and Notice of General Meeting
7th May 20247:00 amRNSProposed conditional disposal of Vanchem
23rd Apr 20247:01 amRNSQ1 2024 Operational & Corporate Update
23rd Apr 20247:00 amRNSMineral Resources and Reserves Annual Update
14th Mar 20249:32 amRNSFurther Update on Outstanding Funds
14th Mar 20247:00 amRNSTR-1 Notification of Major Holdings
7th Mar 20243:00 pmRNSTR-1 Notification of Major Holdings
29th Feb 20245:30 pmRNSFurther Update on Outstanding Funds
16th Feb 20247:08 amRNSFurther update on Outstanding Funds
5th Feb 20247:08 amRNSFull year 2023 Operational Update
2nd Feb 20242:30 pmRNSForm 8.3 of the Takeover Code
1st Feb 20247:00 amRNSCompletion of Convertible Loan Note Refinancing
29th Jan 20244:25 pmRNSResignation of Finance Director
19th Jan 20244:32 pmRNSFurther Update on Outstanding Funds

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.